EUVIMEDEUVIMED entdecken
Open Access

Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy

Xiao-Yan Han, Ling-Jie Kong, Duo Li, Ming Tong, Xiu-Miao Li, Chen Zhao, Qin Jiang, Biao Yan

Theranostics · 2024 · 14 (9) · 3509-3525

DOI: 10.7150/thno.96946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Xiao-Yan Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Eye Hospital, Nanjing Medical University, Nanjing 210000, China. Hauptthemen laut MEDLINE: Glycolysis, Endothelial Cells, Choroidal Neovascularization. Die Arbeit wurde bisher 27-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Current treatments for ocular angiogenesis primarily focus on blocking the activity of vascular endothelial growth factor (VEGF), but unfavorable side effects and unsatisfactory efficacy remain issues. The identification of novel targets for anti-angiogenic treatment is still needed.

Methods

We investigated the role of tsRNA-1599 in ocular angiogenesis using endothelial cells, a streptozotocin (STZ)-induced diabetic model, a laser-induced choroidal neovascularization model, and an oxygen-induced retinopathy model. CCK-8 assays, EdU assays, transwell assays, and matrigel assays were performed to assess the role of tsRNA-1599 in endothelial cells. Retinal digestion assays, Isolectin B4 (IB4) staining, and choroidal sprouting assays were conducted to evaluate the role of tsRNA-1599 in ocular angiogenesis. Transcriptomic analysis, metabolic analysis, RNA pull-down assays, and mass spectrometry were utilized to elucidate the mechanism underlying angiogenic effects mediated by tsRNA-1599. Results: tsRNA-1599 expression was up-regulated in experimental ocular angiogenesis models and endothelial cells in response to angiogenic stress. Silencing of tsRNA-1599 suppressed angiogenic effects in endothelial cells in vitro and inhibited pathological ocular angiogenesis in vivo. Mechanistically, tsRNA-1599 exhibited little effect on VEGF signaling but could cause reduced glycolysis and NAD+/NADH production in endothelial cells by regulating the expression of HK2 gene through interacting with YBX1, thus affecting endothelial effects.

Conclusions

Targeting glycolytic reprogramming of endothelial cells by a tRNA-derived small RNA represents an exploitable therapeutic approach for ocular neovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycolysisEndothelial CellsChoroidal NeovascularizationAnimalsMiceHumansY-Box-Binding Protein 1Angiogenesis InhibitorsHexokinaseDiabetes Mellitus, ExperimentalMice, Inbred C57BLMaleDisease Models, AnimalNeovascularization, PathologicVascular Endothelial Growth Factor ADiabetic RetinopathyHuman Umbilical Vein Endothelial CellsRNA, Small Untranslated

Stichwörter der Autor:innen

AngiogenesisEndothelial metabolismGlycolytic fluxOcular neovascular diseasetsRNAs

Substanzen

Y-Box-Binding Protein 1Angiogenesis InhibitorsHexokinasehexokinase 2, mouseYBX1 protein, humanVascular Endothelial Growth Factor ARNA, Small Untranslated

Autor:innen und Institutionen

  • The Affiliated Eye Hospital, Nanjing Medical University, Nanjing 210000, China.
  • Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
  • The Fourth School of Clinical Medicine, Nanjing Medical University, Nanjing 210000, China.
  • Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.

Zitieren

APA

Han, X. Y., Kong, L. J., Li, D., Tong, M., Li, X. M., Zhao, C., Jiang, Q., & Yan, B. (2024). Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy. Theranostics, 14(9), 3509-3525. https://doi.org/10.7150/thno.96946

Vancouver

Han XY, Kong LJ, Li D, Tong M, Li XM, Zhao C, et al. Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy. Theranostics. 2024;14(9):3509-3525. doi:10.7150/thno.96946

BibTeX
@article{Han2024,
  author = {Han, Xiao-Yan and Kong, Ling-Jie and Li, Duo and Tong, Ming and Li, Xiu-Miao and Zhao, Chen and Jiang, Qin and Yan, Biao},
  title = {Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy},
  journal = {Theranostics},
  year = {2024},
  volume = {14},
  number = {9},
  pages = {3509--3525},
  doi = {10.7150/thno.96946}
}
Kostenlos starten →